The New Biomarkers Clinicians Need to Know for Precision Therapy in Lung Cancer

Get up to date on the latest biomarkers to guide clinical decisions in lung cancer with downloadable slides and the on-demand Webcast from a dynamic expert-led Webinar.

Share

Program Content

Activities

Biomarker-directed Therapy in NSCLC
Integrating Recently Approved Biomarker-directed Therapy Into Clinical Practice
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: October 15, 2020

Expires: October 14, 2021

Emerging Biomarkers in NSCLC
Emerging Biomarkers Poised to Change the Treatment Landscape in NSCLC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: October 15, 2020

Expires: October 14, 2021

<i>EP:</i> New Biomarkers in NSCLC
ExpressPoints: The New Biomarkers Clinicians Need to Know for Precision Therapy in Lung Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: October 23, 2020

Expires: October 22, 2021

Activities

Biomarkers in Lung Cancer
The New Biomarkers Clinicians Need to Know for Precision Therapy in Lung Cancer
Congratulations: You achieved a completion on 04/09/2022

Faculty

cover img faculity

Edward S. Kim, MD

Chief, Section of Head and Neck Medical Oncology
Associate Professor, Thoracic/Head and Neck Medical Oncology
University of Texas M. D. Anderson Cancer Center
Houston, Texas

cover img faculity

Sandip P. Patel, MD

Professor, Medical Oncology, UC San Diego
Leader, Experimental Therapeutics
Deputy Director, Sanford Stem Cell Clinical Center
Co-Leader, Solid Tumor Therapeutics Program
Medical Director, Clinical Research Informatics
La Jolla, California

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Daiichi Sankyo, Inc.

Merck Sharp & Dohme Corp.